Cooper Companies may strongly outperform the S&P 500 going forward, especially in a recessionary environment, rebounding from 2025's sell-off. COO trades at decade-low enterprise valuations, with renewed insider buying, positive trading momentum, and a history of resilience during economic downturns. The company leads the global contact lens market, maintains a solid balance sheet, and just exp...
SAN RAMON, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today its Board of Directors has approved a $1 billion increase in the Company's share repurchase program. The share repurchase program now totals $2 billion.
The Cooper Companies, Inc. (NASDAQ:COO ) Wells Fargo 20th Annual Healthcare Conference 2025 September 3, 2025 3:00 PM EDT Company Participants Albert White - President, CEO & Non-Independent Director Conference Call Participants Larry Biegelsen - Wells Fargo Securities, LLC, Research Division Presentation Larry Biegelsen Senior Medical Device Equity Research Analyst All right. Welcome back.
The stock of medical device specialist Cooper Companies (COO 0.13%) was hurting on the second-to-last trading day of the week. It sank to a 13% loss on the day, following the publication of the company's latest quarterly earnings release.
The Cooper Companies, Inc. (NASDAQ:COO ) Q3 2025 Earnings Conference Call August 27, 2025 5:00 PM ET Company Participants Albert G. White - President, CEO & Non-Independent Director Brian G.
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.